🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 7 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/04/1999 | 76,75 | 76,93 | 75,56 | 76,28 | -0,23% | 1,79% | 4.224.278 |
| 31/03/1999 | 78,13 | 78,72 | 76,46 | 76,46 | -2,58% | 2,90% | 3.981.247 |
| 30/03/1999 | 77,17 | 78,66 | 76,93 | 78,48 | +0,61% | 2,24% | 3.058.169 |
| 29/03/1999 | 77,29 | 78,48 | 77,11 | 78,01 | +1,71% | 1,77% | 3.767.560 |
| 26/03/1999 | 78,01 | 78,07 | 76,57 | 76,69 | -2,65% | 1,91% | 4.296.066 |
| 25/03/1999 | 78,54 | 78,96 | 77,29 | 78,78 | +0,23% | 2,13% | 4.269.447 |
| 24/03/1999 | 78,96 | 79,14 | 77,53 | 78,60 | -0,75% | 2,04% | 3.911.136 |
| 23/03/1999 | 82,78 | 83,25 | 78,36 | 79,20 | -3,91% | 5,91% | 4.808.224 |
| 22/03/1999 | 82,18 | 83,02 | 81,41 | 82,42 | +0,44% | 1,96% | 2.732.555 |
| 19/03/1999 | 83,25 | 83,37 | 82,06 | 82,06 | +0,00% | 1,58% | 6.392.276 |
| 18/03/1999 | 80,15 | 82,96 | 80,15 | 82,06 | +2,38% | 3,50% | 3.997.910 |
| 17/03/1999 | 81,82 | 81,88 | 79,91 | 80,15 | -2,18% | 2,41% | 4.016.565 |
| 16/03/1999 | 81,11 | 82,54 | 80,99 | 81,94 | +1,93% | 1,91% | 5.421.304 |
| 15/03/1999 | 80,09 | 80,75 | 79,56 | 80,39 | +0,45% | 1,49% | 4.642.954 |
| 12/03/1999 | 79,38 | 80,15 | 77,59 | 80,03 | +1,28% | 3,23% | 8.644.952 |
| 11/03/1999 | 79,38 | 79,38 | 77,53 | 79,02 | +0,00% | 2,33% | 4.679.425 |
| 10/03/1999 | 78,72 | 79,02 | 77,83 | 79,02 | -0,38% | 1,52% | 5.138.763 |
| 09/03/1999 | 78,66 | 79,79 | 77,89 | 79,32 | +0,23% | 2,43% | 4.574.939 |
| 08/03/1999 | 77,65 | 79,79 | 77,53 | 79,14 | +0,23% | 2,92% | 6.287.686 |
| 05/03/1999 | 78,13 | 79,14 | 77,77 | 78,96 | +2,87% | 1,76% | 6.492.360 |
| 04/03/1999 | 74,90 | 76,93 | 74,43 | 76,75 | +2,55% | 3,34% | 5.516.462 |
| 03/03/1999 | 75,74 | 76,04 | 74,43 | 74,84 | -1,26% | 2,13% | 3.681.414 |
| 02/03/1999 | 76,34 | 77,23 | 75,08 | 75,80 | -0,39% | 2,81% | 3.852.343 |
| 01/03/1999 | 77,89 | 77,89 | 75,74 | 76,10 | -2,15% | 2,76% | 3.690.951 |
| 26/02/1999 | 77,65 | 78,24 | 75,26 | 77,77 | +0,85% | 3,84% | 4.470.139 |
| 25/02/1999 | 75,50 | 77,47 | 75,14 | 77,11 | +1,65% | 3,08% | 4.484.392 |
| 24/02/1999 | 76,81 | 78,18 | 75,62 | 75,86 | -1,93% | 3,34% | 3.715.474 |
| 23/02/1999 | 78,01 | 78,24 | 76,63 | 77,35 | -0,84% | 2,06% | 5.021.911 |
| 22/02/1999 | 75,86 | 78,01 | 75,26 | 78,01 | +3,48% | 3,62% | 7.193.367 |
| 19/02/1999 | 74,25 | 75,86 | 73,59 | 75,38 | +1,44% | 3,05% | 4.694.306 |